I 

115TH CONGRESS 

2D SESSION H. R. 4899 

To amend the Public Health Service Act to provide grants for treatment 

of heroin, opioids, cocaine, methamphetamine, 3,4- 

methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) 

abuse, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 30, 2018 

Mr. CARTWRIGHT (for himself, Mr. PAYNE, and Ms. NORTON) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to provide grants 

for treatment of heroin, opioids, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), 

and phencyclidine (PCP) abuse, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Access to Substance 

5 Abuse Treatment Act of 2018’’. 

6 SEC. 2. PURPOSE. 

7 It is the purpose of this Act to— 


daltland on DSKBBV9HB2PROD with BILLS
2 

•HR 4899 IH

1 (1) reduce crime and improve public safety by 

2 making treatment for heroin, opioids, cocaine, meth3 amphetamine, 3,4-methylenedioxymethamphetamine 

4 (ecstasy), and phencyclidine (PCP) abuse available 

5 to every American who needs it; 

6 (2) keep families together by encouraging alter7 natives to incarceration for nonviolent drug law of8 fenses; 

9 (3) help identify root causes and most effective 

10 treatment methods for heroin, opioids, cocaine, 

11 methamphetamine, 3,4-methylenedioxymethamphet12 amine, and phencyclidine abuse; and 

13 (4) expand research into cutting-edge treatment 

14 methods for stimulant abuse. 

15 SEC. 3. HEROIN, OPIOIDS, COCAINE, METHAMPHETAMINE, 

16 3,4-METHYLENEDIOXYMETHAMPHETAMINE 

17 (ECSTASY), AND PHENCYCLIDINE (PCP) 

18 TREATMENT AND WRAP-AROUND PROGRAMS. 

19 Subpart 1 of part B of title V of the Public Health 

20 Service Act is amended by inserting after section 514B 

21 (42 U.S.C. 290bb–10) the following new sections: 


daltland on DSKBBV9HB2PROD with BILLS
3 

•HR 4899 IH

1 ‘‘SEC. 514C. INITIATIVE TO INCREASE HEROIN, OPIOIDS, 

2 COCAINE, METHAMPHETAMINE, ECSTASY, 

3 AND PCP TREATMENT CAPACITY. 

4 ‘‘(a) IN GENERAL.—The Secretary may make grants 

5 to State, local, and tribal governments for the purpose of 

6 increasing the availability of treatment for heroin, opioids, 

7 cocaine, methamphetamine, 3,4-methylenedioxymetham8 phetamine (ecstasy), and phencyclidine (PCP) abuse. 

9 ‘‘(b) REQUIREMENTS.— 

10 ‘‘(1) IN GENERAL.—To seek a grant under sub11 section (a), a State, local, or tribal government shall 

12 submit an application to the Secretary at such time, 

13 in such manner, and containing such information 

14 and assurances as the Secretary may require. 

15 ‘‘(2) USE OF GRANT FUNDS.—The grants made 

16 under subsection (a) may only be used to— 

17 ‘‘(A) build treatment centers; 

18 ‘‘(B) expand existing treatment centers; 

19 ‘‘(C) hire treatment professionals; 

20 ‘‘(D) provide training and education to 

21 substance abuse professionals, medical profes22 sionals, and educators related to the treatment 

23 of heroin, opioids, cocaine, methamphetamine, 

24 3,4-methylenedioxymethamphetamine, and 

25 phencyclidine abuse; and 


daltland on DSKBBV9HB2PROD with BILLS
4 

•HR 4899 IH

1 ‘‘(E) engage in other activities that the 

2 Secretary has determined are relevant to the 

3 purpose of the grants under subsection (a). 

4 ‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 

5 are authorized to be appropriated such sums as may be 

6 necessary to carry out this section for fiscal years 2019 

7 through 2023. 

8 ‘‘SEC. 514D. HEROIN, OPIOIDS, COCAINE, METHAMPHET9 AMINE, ECSTASY, AND PCP ABUSE TREAT10 MENT VOUCHERS FOR UNDERSERVED POPU11 LATIONS. 

12 ‘‘(a) IN GENERAL.—The Secretary may make grants 

13 to State, local, and tribal governments and nonprofit enti14 ties to provide vouchers to individuals in underserved pop15 ulations for authorized services related to the treatment 

16 of such individuals for heroin, opioids, cocaine, meth17 amphetamine, 3,4-methylenedioxymethamphetamine (ec18 stasy), and phencyclidine (PCP) abuse. 

19 ‘‘(b) REQUIREMENTS.— 

20 ‘‘(1) APPLICATION.—To seek a grant under 

21 subsection (a), a State, local, or tribal government 

22 or a nonprofit entity shall submit an application to 

23 the Secretary at such time, in such manner, and 

24 containing such information and assurances as the 

25 Secretary may require, including a description of the 


daltland on DSKBBV9HB2PROD with BILLS
5 

•HR 4899 IH

1 method that such State, government, or entity will 

2 use— 

3 ‘‘(A) to identify individuals who would ben4 efit from treatment for heroin, opioids, cocaine, 

5 methamphetamine, 3,4-methylenedioxymetham6 phetamine, or phencyclidine abuse; 

7 ‘‘(B) to identify if such individuals are in 

8 underserved populations; and 

9 ‘‘(C) to provide vouchers to such individ10 uals in such populations. 

11 ‘‘(2) PRESERVATION OF CHOICE.—A recipient 

12 of a grant under this section may not restrict the 

13 ability of an individual receiving a voucher under 

14 this section to use the voucher to pay for authorized 

15 services furnished by any provider of authorized 

16 services, so long as the provider of such services 

17 meets all applicable State licensure or certification 

18 requirements regarding the provision of such serv19 ices. 

20 ‘‘(3) DURATION OF AWARD.—With respect to a 

21 grant under this section, the period during which 

22 payments under such grant are made to the grant 

23 recipient may not exceed five years. 

24 ‘‘(4) MATCHING FUNDS.—The Secretary may 

25 require that recipients of grants under this section 


daltland on DSKBBV9HB2PROD with BILLS
6 

•HR 4899 IH

1 provide non-Federal matching funds, as determined 

2 appropriate by the Secretary, to ensure the commit3 ment of the grant recipients to the provision of 

4 vouchers for treatment to individuals who use her5 oin, opioids, cocaine, methamphetamine, 3,4- 

6 methylenedioxymethamphetamine, or phencyclidine. 

7 Such non-Federal matching funds may be provided 

8 directly or through donations from public or private 

9 entities and may be in cash or in-kind, fairly evalu10 ated, including property, equipment, or services. 

11 ‘‘(5) MAINTENANCE OF EFFORT.—The Sec12 retary may require that grant recipients under this 

13 section agree to maintain expenditures of non-Fed14 eral amounts for authorized services related to the 

15 treatment of heroin, opioids, cocaine, methamphet16 amine, 3,4-methylenedioxymethamphetamine, and 

17 phencyclidine abuse at a level that is not less than 

18 the level of such expenditures maintained by the re19 cipient for the fiscal year preceding the fiscal year 

20 for which the entity receives such a grant. 

21 ‘‘(c) REPORT.— 

22 ‘‘(1) IN GENERAL.—Not later than December 1, 

23 2019, and annually thereafter, the Secretary shall 

24 submit a report to the Congress on the grants under 

25 subsection (a). 


daltland on DSKBBV9HB2PROD with BILLS
7 

•HR 4899 IH

1 ‘‘(2) CONTENTS OF REPORT.—The report under 

2 paragraph (1) shall contain an evaluation of the ef3 fectiveness of the grants made under subsection (a) 

4 in improving access to heroin, opioids, cocaine, 

5 methamphetamine, 3,4-methylenedioxymethamphet6 amine, and phencyclidine treatment for underserved 

7 populations. 

8 ‘‘(d) DEFINITIONS.—For purposes of this section: 

9 ‘‘(1) AUTHORIZED SERVICES.—The term ‘au10 thorized services’ means— 

11 ‘‘(A) treatment for heroin, opioids, cocaine, 

12 methamphetamine, 3,4-methylenedioxymetham13 phetamine, or phencyclidine abuse, including in14 dividual, group, and family counseling regard15 ing such abuse; 

16 ‘‘(B) follow-up services to prevent an indi17 vidual from relapsing into such abuse; 

18 ‘‘(C) wrap-around services, as such term is 

19 defined in section 514E(e)(4); and 

20 ‘‘(D) any additional services specified by 

21 the Secretary. 

22 ‘‘(2) UNDERSERVED POPULATION.—The term 

23 ‘underserved population’ means a population of indi24 viduals who cannot access appropriate substance 

25 abuse treatment (including comprehensive substance 


daltland on DSKBBV9HB2PROD with BILLS
8 

•HR 4899 IH

1 abuse treatment) due to financial, geographical, lan2 guage, socioeconomic, or cultural barriers. 

3 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated such sums as may be 

5 necessary to carry out this section for fiscal years 2019 

6 through 2023. 

7 ‘‘SEC. 514E. COMPREHENSIVE WRAP-AROUND HEROIN, 

8 OPIOIDS, COCAINE, METHAMPHETAMINE, 3,4- 

9 METHYLENEDIOXYMETHAMPHETAMINE (EC10 STASY), AND PHENCYCLIDINE (PCP) TREAT11 MENT SERVICES. 

12 ‘‘(a) IN GENERAL.—The Secretary may make grants 

13 to public, private, and nonprofit entities, Indian tribes, 

14 and tribal organizations to establish programs to provide 

15 for and coordinate the provision of wrap-around services 

16 to heroin, opioids, cocaine, methamphetamine, 3,4- 

17 methylenedioxymethamphetamine, or phencyclidine-af18 fected individuals. 

19 ‘‘(b) MINIMUM QUALIFICATIONS FOR RECEIPT OF

20 AWARD.—To seek a grant under subsection (a), a public, 

21 private, or nonprofit entity, an Indian tribe, or a tribal 

22 organization shall submit an application to the Secretary 

23 at such time, in such manner, and containing such infor24 mation and assurances as the Secretary may require, inVerDate Sep 11 2014 23:22 Jan 31, 2018 Jkt 079200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H4899.IH H4899

daltland on DSKBBV9HB2PROD with BILLS
9 

•HR 4899 IH

1 cluding assurances to the satisfaction of the Secretary 

2 that— 

3 ‘‘(1) the applicant has the capacity to carry out 

4 a program described in subsection (a); 

5 ‘‘(2) the applicant has entered into agreements 

6 with entities in the community involved, through 

7 which the applicant will provide wrap-around serv8 ices; and 

9 ‘‘(3) the applicant, or any entity through which 

10 the applicant will provide such services, meets all ap11 plicable State licensure or certification requirements 

12 regarding the provision of such services. 

13 ‘‘(c) PRIORITY FOR GRANT DISTRIBUTION.—In mak14 ing grants under this section, the Secretary shall give pri15 ority to applications for programs that serve communities 

16 with a high or increasing rate of heroin, opioids, cocaine, 

17 methamphetamine, 3,4-methylenedioxymethamphetamine, 

18 or phencyclidine abuse or addiction, as specified by the 

19 Secretary. 

20 ‘‘(d) REPORTS.—For each year that a public, private, 

21 or nonprofit entity, Indian tribe, or tribal organization re22 ceives a grant under subsection (a) for a program, such 

23 entity, tribe, or organization shall submit to the Secretary 

24 a report on the results and effectiveness of the program. 

25 ‘‘(e) DEFINITIONS.—For purposes of this section: 


daltland on DSKBBV9HB2PROD with BILLS
10 

•HR 4899 IH

1 ‘‘(1) HEROIN, OPIOIDS, COCAINE, METH2 AMPHETAMINE, 3,4- 

3 METHYLENEDIOXYMETHAMPHETAMINE, OR

4 PHENCYCLIDINE-AFFECTED INDIVIDUAL.—The term 

5 ‘heroin, opioids, cocaine, methamphetamine, 3,4- 

6 methylenedioxymethamphetamine, or phencyclidine7 affected individual’ means an individual who— 

8 ‘‘(A)(i) resided in a residential inpatient 

9 treatment facility for the treatment of heroin, 

10 opioids, cocaine, methamphetamine, 3,4- 

11 methylenedioxymethamphetamine, or phencycli12 dine abuse or addiction; or 

13 ‘‘(ii) received treatment for heroin, opioids, 

14 cocaine, methamphetamine, 3,4-methylenedioxy15 methamphetamine, or phencyclidine abuse or 

16 addiction from an intensive outpatient treat17 ment facility; and 

18 ‘‘(B) after successful completion of such 

19 treatment reenters the community. 

20 ‘‘(2) INTENSIVE OUTPATIENT TREATMENT FA21 CILITY.—The term ‘intensive outpatient treatment 

22 facility’ means a facility that provides treatment for 

23 substance abuse and that, with respect to an indi24 vidual receiving such treatment— 


daltland on DSKBBV9HB2PROD with BILLS
11 

•HR 4899 IH

1 ‘‘(A) provides a minimum of seven hours of 

2 treatment for substance abuse during a week; 

3 ‘‘(B) provides regularly scheduled treat4 ment sessions within a structured program; and 

5 ‘‘(C) ensures that the treatment sessions 

6 are led by health professionals or clinicians. 

7 ‘‘(3) RESIDENTIAL INPATIENT TREATMENT FA8 CILITY.—The term ‘residential inpatient treatment 

9 facility’ means a facility that provides treatment for 

10 substance abuse in which health professionals and 

11 clinicians provide a planned regimen of 24-hour pro12 fessionally directed evaluation, care, and treatment 

13 for such substance abuse in an inpatient setting, in14 cluding 24-hour observation and monitoring. 

15 ‘‘(4) WRAP-AROUND SERVICES.—The term 

16 ‘wrap-around services’ means, with respect to a her17 oin, opioids, cocaine, methamphetamine, 3,4- 

18 methylenedioxymethamphetamine, or phencyclidine19 affected individual, the following services: 

20 ‘‘(A) Medical services. 

21 ‘‘(B) Dental services. 

22 ‘‘(C) Mental health services. 

23 ‘‘(D) Child care services. 

24 ‘‘(E) Job training services. 

25 ‘‘(F) Housing assistance. 


daltland on DSKBBV9HB2PROD with BILLS
12 

•HR 4899 IH

1 ‘‘(G) Training in parenting. 

2 ‘‘(H) Prevention services for family mem3 bers, with respect to heroin, opioids, cocaine, 

4 methamphetamine, 3,4-methylenedioxymetham5 phetamine, and phencyclidine abuse or addic6 tion. 

7 ‘‘(I) Transportation assistance services for 

8 purposes of participation in the services listed 

9 in subparagraphs (A) through (H). 

10 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 

11 are authorized to be appropriated such sums as may be 

12 necessary to carry out this section for fiscal years 2019 

13 through 2023.’’. 

14 SEC. 4. EXTENSION AND EXPANSION OF RESIDENTIAL 

15 TREATMENT PROGRAM FOR PREGNANT AND 

16 POSTPARTUM WOMEN TO INCLUDE CARE17 GIVER PARENTS. 

18 Section 508 of the Public Health Service Act (42 

19 U.S.C. 290bb–1) is amended— 

20 (1) in the heading, by striking ‘‘PREGNANT AND

21 POSTPARTUM WOMEN’’ and inserting ‘‘CAREGIVER

22 PARENTS, INCLUDING PREGNANT WOMEN’’; 

23 (2) in subsection (a)— 

24 (A) in the matter preceding paragraph 

25 (1)— 


daltland on DSKBBV9HB2PROD with BILLS
13 

•HR 4899 IH

1 (i) by inserting ‘‘, Indian tribes, and 

2 tribal organizations’’ after ‘‘nonprofit pri3 vate entities’’; and 

4 (ii) by striking ‘‘pregnant and 

5 postpartum women treatment for sub6 stance abuse’’ and inserting ‘‘caregiver 

7 parents, including pregnant women, treat8 ment for substance abuse (including treat9 ment for addiction to heroin, opioids, co10 caine, methamphetamine, 3,4-methylene11 dioxymethamphetamine (ecstasy), or phen12 cyclidine (PCP))’’; 

13 (B) in each of paragraphs (1), (2), and 

14 (3), by striking ‘‘the women’’ and inserting 

15 ‘‘such parents’’ each place it appears; and 

16 (C) in paragraph (3), by inserting ‘‘supple17 mental’’ before ‘‘services’’; 

18 (3) in subsection (b)— 

19 (A) in paragraph (1), by inserting ‘‘, In20 dian tribes, or tribal organizations’’ after ‘‘non21 profit private entities’’; and 

22 (B) in paragraph (2)— 

23 (i) by striking ‘‘the services’’ and in24 serting ‘‘such services’’; and 


daltland on DSKBBV9HB2PROD with BILLS
14 

•HR 4899 IH

1 (ii) by striking ‘‘woman’’ and insert2 ing ‘‘caregiver parent’’; 

3 (4) in subsection (c)— 

4 (A) in paragraph (1), by striking ‘‘eligible 

5 woman’’ and inserting ‘‘eligible caregiver par6 ent’’; and 

7 (B) by striking ‘‘the women’’ and ‘‘the 

8 woman’’ each place either term appears and in9 serting ‘‘such parent’’; 

10 (5) in subsection (d)— 

11 (A) in the matter proceeding paragraph 

12 (1), by striking ‘‘woman’’ and inserting ‘‘care13 giver parent’’; 

14 (B) in paragraphs (3) and (4), by striking 

15 ‘‘the woman’’ and inserting ‘‘such parent’’ each 

16 place it appears; 

17 (C) in paragraph (9)— 

18 (i) by striking ‘‘the women’’ and in19 serting ‘‘such parent’’ each place it ap20 pears; 

21 (ii) by striking ‘‘units’’ and inserting 

22 ‘‘unit’’; and 

23 (iii) by striking ‘‘of parents’’ and in24 serting ‘‘of the parents of such parent’’; 


daltland on DSKBBV9HB2PROD with BILLS
15 

•HR 4899 IH

1 (D) in paragraph (10), by inserting ‘‘, In2 dian tribes, or tribal organizations’’ after ‘‘enti3 ties’’; and 

4 (E) in paragraph (11)— 

5 (i) by striking ‘‘the women’’ and in6 serting ‘‘such parent’’; and 

7 (ii) by striking ‘‘their children’’ and 

8 inserting ‘‘the children of such parent’’; 

9 (6) in subsection (f)(1), in the matter pro10 ceeding subparagraph (A) by inserting ‘‘, Indian 

11 tribes, or tribal organizations’’ after ‘‘public or pri12 vate entities’’; 

13 (7) in subsection (g)— 

14 (A) by striking ‘‘identify women’’ and in15 serting ‘‘identify caregiver parents’’; and 

16 (B) by striking ‘‘the women’’ and inserting 

17 ‘‘such parents’’; 

18 (8) in subsection (h)(1), by striking ‘‘pregnant 

19 and postpartum women’’ and inserting ‘‘caregiver 

20 parents’’; 

21 (9) in subsection (j)— 

22 (A) in the matter proceeding paragraph 

23 (1)— 

24 (i) by striking ‘‘to on behalf’’ and in25 serting ‘‘to or on behalf’’; and 


daltland on DSKBBV9HB2PROD with BILLS
16 

•HR 4899 IH

1 (ii) by striking ‘‘woman’’ and insert2 ing ‘‘caregiver parent’’; 

3 (B) in paragraph (2), by striking ‘‘the 

4 woman’’ and inserting ‘‘such parent’’; and 

5 (C) in paragraph (3), by striking ‘‘woman’’ 

6 and inserting ‘‘parent’’; 

7 (10) in subsection (k)(2), by striking ‘‘women’’ 

8 and inserting ‘‘caregiver parents’’; 

9 (11) in subsection (l), by striking ‘‘such agree10 ments’’ and inserting ‘‘the funding agreements 

11 under this section’’; 

12 (12) by amending subsection (m) to read as fol13 lows: 

14 ‘‘(m) USE OF FUNDS; PRIORITY FOR CERTAIN

15 AREAS SERVED.— 

16 ‘‘(1) USE OF FUNDS.—A funding agreement for 

17 an award under subsection (a) for an applicant is 

18 that funds awarded under subsection (a) to such ap19 plicant shall be used for programs according to the 

20 following order of priority: 

21 ‘‘(A) For a program that provides services 

22 to caregiver parents who are pregnant and 

23 postpartum women. 

24 ‘‘(B) For a program that provides services 

25 to caregiver parents who are single parents and 


daltland on DSKBBV9HB2PROD with BILLS
17 

•HR 4899 IH

1 the sole caregivers with respect to their chil2 dren. 

3 ‘‘(C) For a program that provides services 

4 to any caregiver parents. 

5 ‘‘(2) PRIORITY FOR CERTAIN AREAS SERVED.— 

6 In making awards under subsection (a), the Director 

7 shall give priority to any entity, tribe, or organiza8 tion that agrees to use the award for a program 

9 serving an area that— 

10 ‘‘(A) is an area determined by the Director 

11 to have a shortage of family-based substance 

12 abuse treatment options; or 

13 ‘‘(B) is determined by the Director to have 

14 high rates of addiction to heroin, opioids, co15 caine, methamphetamine, 3,4-methylenedioxy16 methamphetamine, or phencyclidine.’’; 

17 (13) in subsection (p)— 

18 (A) by striking ‘‘October 1, 1994’’ and in19 serting ‘‘January 1, 2019’’; 

20 (B) by striking ‘‘Committee on Labor and 

21 Human Resources’’ and inserting ‘‘Committee 

22 on Health, Education, Labor, and Pensions’’; 

23 and 

24 (C) by striking the third sentence; 

25 (14) in subsection (q)— 


daltland on DSKBBV9HB2PROD with BILLS
18 

•HR 4899 IH

1 (A) by redesignating paragraphs (2), (3), 

2 (4), and (5) as paragraphs (3), (4), (5), and 

3 (6), respectively; 

4 (B) by inserting after paragraph (1) the 

5 following new paragraph: 

6 ‘‘(2) The term ‘caregiver parent’ means, with 

7 respect to a child, a parent or legal guardian with 

8 whom the child resides, and includes a pregnant 

9 woman.’’; and 

10 (C) by amending paragraph (3), as redes11 ignated by subparagraph (A) of this paragraph, 

12 to read as follows: 

13 ‘‘(3) The term ‘eligible caregiver parent’ means 

14 a caregiver parent who has been admitted to a pro15 gram operated pursuant to subsection (a).’’; and 

16 (15) in subsection (r), by striking ‘‘to fiscal 

17 years 2001 through 2003’’ and inserting ‘‘for fiscal 

18 years 2019 through 2023’’. 

19 SEC. 5. EFFECTIVENESS OF STIMULANT TREATMENT 

20 METHODS. 

21 (a) RESEARCH.—The Director of the National Insti22 tute on Drug Abuse shall conduct research, directly or 

23 through contract with another entity, on the effectiveness 

24 of the use of agonist and antagonist drugs to reduce the 


daltland on DSKBBV9HB2PROD with BILLS
19 

•HR 4899 IH

1 problems associated with stimulant abuse, including co2 caine and methamphetamine abuse. 

3 (b) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated such sums as may be 

5 necessary to carry out this section for fiscal years 2019 

6 through 2023. 

7 SEC. 6. IOM STUDY ON DRUG TREATMENTS FOR STIMU8 LANT ABUSE. 

9 (a) REPORT.—The Secretary of Health and Human 

10 Services shall seek to enter into a contract with the Insti11 tute of Medicine of the National Academies to complete 

12 a literature review and submit a report to Congress on 

13 the effectiveness of agonist and antagonist drugs for the 

14 treatment of stimulant abuse, including cocaine and meth15 amphetamine abuse. 

16 (b) AUTHORIZATION OF APPROPRIATIONS.—There 

17 are authorized to be appropriated such sums as may be 

18 necessary to carry out this section for fiscal years 2019 

19 through 2023. 

20 SEC. 7. GAO EVALUATION OF THE IMPACT OF THIS LEGIS21 LATION. 

22 (a) STUDY ON THE LEVEL OF FUNDING FOR TREAT23 MENT.—The Comptroller General of the United States 

24 shall conduct a study on— 


daltland on DSKBBV9HB2PROD with BILLS
20 

•HR 4899 IH

1 (1) the impact of the programs authorized by 

2 this Act (including the amendments made by this 

3 Act) on the effectiveness and availability of treat4 ment for heroin, opioids, cocaine, methamphetamine, 

5 3,4-methylenedioxymethamphetamine, and phencycli6 dine abuse; 

7 (2) whether the level of Federal funding avail8 able for the treatment of heroin, opioids, cocaine, 

9 methamphetamine, 3,4-methylenedioxymethamphet10 amine, and phencyclidine abuse meets, exceeds, or is 

11 less than the amount necessary to provide adequate 

12 treatment for such abuse; and 

13 (3) the impact of effective treatment of heroin, 

14 opioids, cocaine, methamphetamine, 3,4-methylene15 dioxymethamphetamine, and phencyclidine abuse on 

16 cost savings due to the reduced need for criminal 

17 justice and other services. 

18 (b) REPORTS.— 

19 (1) INTERIM REPORT.—Not later than the last 

20 day of the two-year period beginning on the date of 

21 enactment of this Act, the Comptroller General shall 

22 submit to Congress a report on the interim findings 

23 of the study under subsection (a). 

24 (2) FINAL REPORT.—Not later than 3 years 

25 after the date on which the report under paragraph 


daltland on DSKBBV9HB2PROD with BILLS
21 

•HR 4899 IH

1 (1) is submitted to Congress, the Comptroller Gen2 eral shall submit to Congress a report on the find3 ings of the study under subsection (a). 

4 SEC. 8. NO ADDITIONAL APPROPRIATIONS. 

5 This Act, and the amendments made by this Act, 

6 shall not be construed to increase the amount of appro7 priations that are authorized to be approved for any fiscal 

8 year. 

Æ 


daltland on DSKBBV9HB2PROD with BILLS